Lobular Breast Carcinoma: Clinical Trials

15 trials for Lobular Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 4 active not recruiting, 4 completed, 1 unknown. 4 Not applicable, 4 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1
Phase 24Recruiting 3, Completed 1
Early Phase 11Completed 1
Phase 31Active not recruiting 1

Follow Lobular Breast Carcinoma: new trials by email Literature Review of Lobular Breast Carcinoma trials Research Report on Lobular Breast Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
FES, PET/MRI A, Translational analysis - Breast Cancer Female, Lobular Breast Carcinoma
Phase 2RecruitingUniversità Vita-Salute San Raffaele1192026-06-092026-06-12
Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study
Upfront Breast Surgery, Adjuvant Radiotherapy, Endocrine Therapy - Lobular Breast Carcinoma
RecruitingIstituto Oncologico Veneto IRCCS2502026-05-012026-09-02
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Neoadjuvant endocrine therapy - Breast Cancer, HER2-negative Breast Cancer
Phase 2RecruitingMemorial Sloan Kettering Cancer Center1762026-03-132026-06-04
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
18F-Fluoroestradiol PET/CT - Breast Cancer, Lobular Breast Carcinoma
Active not recruitingMemorial Sloan Kettering Cancer Center72024-08-132026-07-14
Biomarkers to Detect Endocrine Therapy Resistance
18F-fluorofuranylnorprogesterone, Liquid Biopsy, Positron Emission Tomography/Computed Tomography - Metastatic Cancer, Breast Cancer
Phase 2RecruitingUniversity of Wisconsin, Madison82024-04-302026-08-25
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Blood Specimen - Metastatic Breast Cancer, Lobular Breast Carcinoma
RecruitingUniversity of California, San Francisco1502023-12-202026-09-02
Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT
68Ga-FAPI-46 PET scan - Lobular Breast Carcinoma
Not applicableActive not recruitingCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer402023-11-162026-07-07
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Palliative radiotherapy - Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV
Not applicableRecruitingMemorial Sloan Kettering Cancer Center262023-07-242026-09-02
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
Illumina panel - Lobular Breast Carcinoma, Lobular in Situ Breast Carcinoma
Active not recruitingEuropean Institute of Oncology8002022-05-162025-12-04
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
Crizotinib Oral Capsule [Xalkori], Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic] - Lobular Breast Carcinoma, Gastric Cancer
Phase 2CompletedRoyal Marsden NHS Foundation Trust332019-05-092025-10-30
Living Well After Breast Surgery
Breast reconstruction decision aid, Educational website - Breast Cancer Female, Stage I Breast Cancer
Not applicableCompletedUniversity of Texas at Austin172019-02-182021-11-02
CDH1 Germline Mutations in Lobular Breast Cancer
Lobular Breast Carcinoma, CDH1 Gene Inactivation
CompletedEuropean Institute of Oncology4212018-12-012025-12-04
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Radiation Therapy, Questionnaire Administration, Quality-of-Life Assessment - Ductal Breast Carcinoma, Invasive Breast Carcinoma
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology8982018-03-122026-02-24
Broccoli Sprout Extract in Treating Patients With Breast Cancer
Broccoli Sprout Extract, Laboratory Biomarker Analysis, Pharmacological Study - Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ
Early Phase 1CompletedRoswell Park Cancer Institute302013-05-212019-10-31
Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy
PET scan after course 1 and surgery after 8 courses - Invasive Ductal Carcinoma, Lobular Breast Carcinoma
Not applicableUnknownAuxilio Mutuo Cancer Center802007-07-012012-07-13

Narrower conditions

Carcinoma, Lobular (15)  ·  Breast Neoplasms (7)  ·  Carcinoma, Ductal, Breast (4)  ·  Carcinoma, Intraductal, Noninfiltrating (2)  ·  Neoplasm Metastasis (2)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Gastrointestinal Neoplasms (1)  ·  Inflammatory Breast Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Neoplastic Cells, Circulating (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)

Broader conditions

Adenocarcinoma (15)  ·  Breast Diseases (15)  ·  Carcinoma (15)  ·  Neoplasms by Histologic Type (15)  ·  Neoplasms by Site (15)  ·  Neoplasms, Ductal, Lobular, and Medullary (15)  ·  Neoplasms, Glandular and Epithelial (15)  ·  Skin Diseases (15)  ·  Skin and Connective Tissue Diseases (15)  ·  Neoplasms (14)  ·  Breast Neoplasms (8)  ·  Carcinoma, Ductal (4)  ·  Carcinoma in Situ (3)  ·  Breast Carcinoma In Situ (2)  ·  Digestive System Diseases (2)

Interventions

Blood Specimen Collection (1)  ·  Crizotinib (1)  ·  Drug Therapy (1)  ·  Drugs, Generic (1)  ·  Fulvestrant (1)  ·  Liquid Biopsy (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  Radiotherapy (1)  ·  Radiotherapy, Adjuvant (1)

Sponsors

Memorial Sloan Kettering Cancer Center (3)  ·  European Institute of Oncology (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Auxilio Mutuo Cancer Center (1)  ·  Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer (1)  ·  Istituto Oncologico Veneto IRCCS (1)  ·  Roswell Park Cancer Institute (1)  ·  Royal Marsden NHS Foundation Trust (1)  ·  University of California, San Francisco (1)  ·  University of Texas at Austin (1)  ·  University of Wisconsin, Madison (1)  ·  Università Vita-Salute San Raffaele (1)

Countries

United States (8)  ·  Italy (4)  ·  Canada (1)  ·  Monaco (1)  ·  Puerto Rico (1)  ·  United Kingdom (1)

Top investigators

Atif Khan, MD (1)  ·  Fernando Cabanillas, MD (1)  ·  Florent Hugonnet, MD (1)  ·  Francesco Milardi, MD (1)  ·  Giovanni Corso, MD (1)  ·  Giovanni Corso, PhD, MD (1)  ·  Jessica Young (1)  ·  Marina Sharifi, MD, PHD (1)  ·  Matthew Poppe, MD (1)  ·  Professor Peter Schmid (1)  ·  Rita Mukhtar, MD (1)  ·  Somali Gavane, MD (1)

Results publications

PMID 35119530

NIH funding

K07CA148888 (1), P30CA016056 (1)